New pill targets brain Cancer's weakness in early human trial
Disease control
Not yet recruiting
This is a first-in-human study to find a safe dose of an experimental oral drug called GLIX1 for adults with aggressive brain tumors (high-grade glioma or glioblastoma) that have returned or worsened after standard treatments. The main goal is to check the drug's safety and side …
Phase: PHASE1 • Sponsor: Tetragon Biosciences Ltd • Aim: Disease control
Last updated Mar 27, 2026 12:37 UTC